Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.0:1
Daily Buy & Sell Volume
Transactions (336)
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
6,121
Price
$104.78
Total Value
$641.36K
Shares Held After
324,979
% of Holdings
1.8%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
12,425
Price
$103.78
Total Value
$1.29M
Shares Held After
331,100
% of Holdings
3.6%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
11,354
Price
$103.21
Total Value
$1.17M
Shares Held After
343,525
% of Holdings
3.2%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
6,901
Price
$50.00
Total Value
$345.05K
Shares Held After
12,546
% of Holdings
35.5%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
10,000
Price
$33.00
Total Value
$330.00K
Shares Held After
37,500
% of Holdings
21.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,100
Price
$64.02
Total Value
$262.46K
Shares Held After
767,780
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,900
Price
$63.14
Total Value
$372.52K
Shares Held After
771,880
% of Holdings
0.8%
Vir Biotechnology, Inc. (VIR)
De Backer Marianne — Director
Shares
72,559
Price
$9.16
Total Value
$664.35K
Shares Held After
948,145
% of Holdings
7.1%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
55,000
Price
$5.69
Total Value
$313.14K
Shares Held After
340,106
% of Holdings
13.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
199
Price
$333.94
Total Value
$66.45K
Shares Held After
9,443
% of Holdings
2.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
293
Price
$331.89
Total Value
$97.24K
Shares Held After
9,642
% of Holdings
2.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
829
Price
$330.46
Total Value
$273.95K
Shares Held After
9,935
% of Holdings
7.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
909
Price
$329.76
Total Value
$299.75K
Shares Held After
10,764
% of Holdings
7.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
56
Price
$320.14
Total Value
$17.93K
Shares Held After
11,673
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$566.00
Total Value
$90.56K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
122
Price
$564.22
Total Value
$68.84K
Shares Held After
40,673
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
716
Price
$563.38
Total Value
$403.38K
Shares Held After
40,795
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
402
Price
$562.54
Total Value
$226.14K
Shares Held After
41,511
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$561.51
Total Value
$291.99K
Shares Held After
41,913
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
558
Price
$560.10
Total Value
$312.54K
Shares Held After
42,433
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
922
Price
$559.41
Total Value
$515.78K
Shares Held After
42,991
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,806
Price
$558.31
Total Value
$1.01M
Shares Held After
43,913
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,386
Price
$557.21
Total Value
$772.29K
Shares Held After
45,719
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,219
Price
$556.19
Total Value
$678.00K
Shares Held After
47,105
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,209
Price
$555.25
Total Value
$671.30K
Shares Held After
48,324
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$553.96
Total Value
$221.58K
Shares Held After
49,533
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$552.65
Total Value
$44.21K
Shares Held After
49,933
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$566.01
Total Value
$113.20K
Shares Held After
18,876
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
82
Price
$564.43
Total Value
$46.28K
Shares Held After
19,076
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
539
Price
$563.47
Total Value
$303.71K
Shares Held After
19,158
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
619
Price
$562.75
Total Value
$348.34K
Shares Held After
19,697
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
645
Price
$561.56
Total Value
$362.20K
Shares Held After
20,316
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
616
Price
$560.18
Total Value
$345.07K
Shares Held After
20,961
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
860
Price
$559.47
Total Value
$481.14K
Shares Held After
21,577
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,679
Price
$558.31
Total Value
$937.41K
Shares Held After
22,437
% of Holdings
7.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,840
Price
$557.19
Total Value
$1.03M
Shares Held After
24,116
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,205
Price
$556.06
Total Value
$670.05K
Shares Held After
25,956
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,158
Price
$555.21
Total Value
$642.94K
Shares Held After
27,161
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
437
Price
$553.97
Total Value
$242.08K
Shares Held After
28,319
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$552.78
Total Value
$66.33K
Shares Held After
28,756
% of Holdings
0.4%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
5,000
Price
$6.32
Total Value
$31.60K
Shares Held After
3,017,000
% of Holdings
0.2%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$34.57
Total Value
$70.32K
Shares Held After
233,592
% of Holdings
0.9%
Lipocine Inc. (LPCN)
Higuchi John W. — Director
Shares
123,000
Price
$2.05
Total Value
$252.15K
Shares Held After
163,797
% of Holdings
75.1%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
102
Price
$5.05
Total Value
$515.10
Shares Held After
65,364
% of Holdings
0.2%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
6,775
Price
$18.50
Total Value
$125.34K
Shares Held After
4,555,741
% of Holdings
0.1%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
44,728
Price
$17.31
Total Value
$774.24K
Shares Held After
4,562,516
% of Holdings
1.0%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
537,754
Price
$16.51
Total Value
$8.88M
Shares Held After
4,607,244
% of Holdings
10.5%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
1,716
Price
$5.05
Total Value
$8.67K
Shares Held After
611,313
% of Holdings
0.3%
Lipocine Inc. (LPCN)
Patel Mahesh V. — Director
Shares
25,000
Price
$2.03
Total Value
$50.75K
Shares Held After
160,679
% of Holdings
15.6%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
525
Price
$5.05
Total Value
$2.65K
Shares Held After
159,562
% of Holdings
0.3%
Showing 51–100 of 336 transactions (page 2 of 7)